PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Oct-2022 Agilent Opens Center of Excellence for Dissolution Products Businesswire
12-Oct-2022 Calidi Biotherapeutics to Present Pre-Clinical SuperNova1 (SNV1) Data at the 2022 SITC Annual Meeting Businesswire
12-Oct-2022 SugarCRM Recognized in the Gartner® Emerging Tech: Tech Innovators for Intelligent CRM Applications Report Businesswire
12-Oct-2022 Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase Businesswire
12-Oct-2022 Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2022 Businesswire
12-Oct-2022 Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread Businesswire
12-Oct-2022 FOXO Technologies Announces First Distribution Partner and Begins Product Rollout in California; Expands Executive Team With Insurance Industry Talent Businesswire
12-Oct-2022 Thermo Fisher Scientific Unveils New Clinical Research Laboratory in Virginia Businesswire
12-Oct-2022 Enveric Biosciences Announces Poster Presentations of Lead Programs at the 2022 International Neurology & Brain Disorders Conference Businesswire
12-Oct-2022 Maternova Appoints Luna Mehrain, MD, MSc, as Chief Medical Officer Businesswire
12-Oct-2022 Apnimed to Participate in the 2nd Annual Needham Biotech Private Company Virtual 1x1 Forum Businesswire
12-Oct-2022 Artificial Intelligence in Oncology Market Report 2022: AI Based Cancer Screening Has Resulted in Reduced Mortality Rates of Some Prevalent Malignancies - ResearchAndMarkets.com Businesswire
12-Oct-2022 KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs Businesswire
12-Oct-2022 Multi-omics Startup Pleno Inc. Announces $40 Million in Series A Funding Led by Deerfield Management with Participation by Foresite Capital Businesswire
12-Oct-2022 Antibe Provides Development Update for Otenaproxesul Businesswire
12-Oct-2022 Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November 2 Businesswire
12-Oct-2022 Linear Health Sciences Recognized for Leading the Way to Safer IV Treatment for Children Businesswire
12-Oct-2022 Vita Therapeutics Closes $31 Million Series B Financing to Develop Cell Therapies for Neuromuscular Diseases and Cancers Businesswire
12-Oct-2022 BeiGene Announces Positive Topline Results from Final Progression-Free Survival Analysis of BRUKINSA® (zanubrutinib) Compared to IMBRUVICA® (ibrutinib) in Phase 3 Chronic Lymphocytic Leukemia (CLL) Trial Businesswire
12-Oct-2022 RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials CluePoints